文献速递食管与纵隔外科

微创食管切除术费用的驱动因素

Drivers of Cost Associated With Minimally Invasive Esophagectomy.
PubMed 文献 · Ann Thorac Surg · 2021-01-29

该研究纳入2008年12月至2020年3月接受微创食管切除术的食管癌患者240例,利用胸外科医师学会数据库与财务数据合并,采用LASSO回归识别费用预测因素。结果显示费用主要来自手术室、住院病房和麻醉后/重症监护病房,术前危险因素和术后并发症是费用驱动因素。

要点

  • 微创食管切除术费用主要来自手术室(30%)、住院病房(30%)和麻醉后/重症监护病房(20%)。
  • 术后呼吸衰竭、肺炎、肾功能衰竭和再次手术显著增加术后费用。
  • 年龄、BMI≥30、FEV1和手术年份是手术费用的术前预测因素。

核心结论

  • 微创食管切除术相关费用由术前危险因素和术后结局驱动。

研究设计与样本

  • 回顾性队列研究,纳入2008年12月至2020年3月接受微创食管切除术的食管癌患者240例,合并胸外科医师学会数据库与财务数据,采用LASSO回归识别费用预测因素。

主要发现

  • 队列中82%患者病理分期≥cT2,90%为腺癌,78%接受新辅助治疗,平均住院时间8.00天(SD 4.13),住院并发症率45%,无死亡。

临床怎么用

  • 识别术前高危因素和预防术后并发症可能有助于降低微创食管切除术的费用变异。
  • 研究数据可用于标准化流程和质量改进,为基于绩效的支付策略提供参考。

局限性

  • 单中心回顾性研究,样本量240例,结论外推需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: In this era of value-based healthcare, costs must be measured alongside patient outcomes to prioritize quality improvement and inform performance-based reimbursement strategies. We sought to identify drivers of costs for patients undergoing minimally invasive esophagectomy for esophageal cancer. METHODS: Patients who underwent minimally invasive esophagectomy for esophageal cancer from December 2008 to March 2020 were included. Our institutional Society of Thoracic Surgeons database was merged with financial data to determine inpatient direct accounting costs in 2020 US dollars for total, operative (surgery and anesthesia), and postoperative (intensive care, floor, radiology, laboratory, etc) services. A supervised machine learning quantitative method, the lasso estimator with 10-fold cross-validation, was applied to identify predictors of costs. RESULTS: In the study cohort (n = 240) most had ≥cT2 pathology (82%), adenocarcinoma histology (90%), and received neoadjuvant therapy (78%). Mean length of stay was 8.00 days (SD, 4.13) with 45% inpatient morbidity rate and no deaths. The largest proportions of cost were from the operating room (30%), inpatient floor (30%), and postanesthesia care/intensive care units (20%). Preoperative predictors of operative costs were age (-5.18% per decade [95% confidence interval {CI}, -9.95 to -0.27], P = .039), body mass index ≥ 30 (+12.9% [95% CI, 0.00-27.5], P = .050), forced expiratory volume in 1 second (-3.24% per 10% forced expiratory volume in 1 second [95% CI, -5.80 to -0.61], P = .017), and year of surgery (+2.55% [95% CI, 0.97-4.15], P = .002). Predictors of postoperative costs were postoperative renal failure (+91.6% [95% CI, 9.93-233.8], P = .022), respiratory failure (+414.6% [95% CI, 158.7-923.6], P < .001), pneumonia (+136.1% [95% CI, 71.1-225.8], P < .001), and reoperation (+60.5% [95% CI, 21.5-111.9], P = .001). CONCLUSIONS: Costs associated with minimally invasive esophagectomy are driven by preoperative risk factors and postoperative outcomes. These data enable surgeons and policymakers to reduce cost variation, improve quality through standardization, and ultimately provide greater value to patients.

来源:Ann Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Panda N, Shagabayeva L, Comrie CE, et al. Drivers of Cost Associated With Minimally Invasive Esophagectomy. Ann Thorac Surg. 2021. PMID: 33524354. doi:10.1016/j.athoracsur.2021.01.023

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。